adriblastina 50 mg /vial polvo liofilizado para solucion inyectable i.v., intravesical.
pfizer italia s.r.l. - doxorubicina (clorhidrato) - doxorubicina (clorhidrato)....50,0 mg
adriblastina 10 mg/vial polvo liofilizado para solucion inyectable i.v. o intravesical.
pfizer italia s.r.l. - doxorubicina (clorhidrato) - doxorubicina (clorhidrato)....10,0 mg / cloruro de sodio al 0.9%....45.0 mg
adriblastina 2 mg / ml solución inyectable i.v., intravesical, intraarterial
pfizer australia pty ltd - doxorubicina (clorhidrato) - doxorubicina (clorhidrato)....2 mg
doxorubicina 2 mg/ml sandoz
sandoz gmbh - doxorrubicina clorhidrato - doxorrubicina clorhidrato....2.00mg
doxorubicina clorhidrato usp 50mg/25ml solución inyectable
al pharma s.a.s. - doxorrubicina clorhidrato - doxorrubicina clorhidrato....2,00 mg
docetaxel accord
accord healthcare s.l.u. - docetaxel - head and neck neoplasms, carcinoma, non-small-cell lung, adenocarcinoma, prostatic neoplasms, breast neoplasms - antineoplastic agents, - breast cancerdocetaxel accord in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:operable node-positive breast cancer;operable node-negative breast cancer.for patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer.docetaxel accord in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.docetaxel accord monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.docetaxel accord in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer w
doxorubicin mylan concentrate for soln for inf 2mg/ml (10ml vial)
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - doxorubicin hydrochloride - concentrate for solution for infusion - doxorubicin hydrochloride 2 mg - antineoplastic agents
doxorubicin mylan concentrate for soln for inf 2mg/ml (25ml vial)
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - doxorubicin hydrochloride - concentrate for solution for infusion - doxorubicin hydrochloride 2 mg - antineoplastic agents
doxorubicin mylan concentrate for soln for inf 2mg/ml (100ml vial)
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - doxorubicin hydrochloride - concentrate for solution for infusion - doxorubicin hydrochloride 2 mg - antineoplastic agents
doxorubicin mylan pdr/conc/soln for infus 2mg/ml (10mg vial)
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - doxorubicin hydrochloride - powder for concentrate for solution for infusion - doxorubicin hydrochloride 2 mg - antineoplastic agents